KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Common Equity (2016 - 2025)

Historic Common Equity for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $18.5 billion.

  • Bristol Myers Squibb's Common Equity rose 1292.41% to $18.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.5 billion, marking a year-over-year increase of 1292.41%. This contributed to the annual value of $18.5 billion for FY2025, which is 1292.41% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Common Equity is $18.5 billion, which was up 1292.41% from $18.6 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Common Equity ranged from a high of $45.7 billion in Q4 2023 and a low of $16.4 billion during Q4 2024
  • For the 5-year period, Bristol Myers Squibb's Common Equity averaged around $28.8 billion, with its median value being $31.8 billion (2022).
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 6412.75% in 2024, then skyrocketed by 1292.41% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Common Equity stood at $44.4 billion in 2021, then increased by 1.81% to $45.2 billion in 2022, then grew by 1.15% to $45.7 billion in 2023, then plummeted by 64.13% to $16.4 billion in 2024, then rose by 12.92% to $18.5 billion in 2025.
  • Its last three reported values are $18.5 billion in Q4 2025, $18.6 billion for Q3 2025, and $17.5 billion during Q2 2025.